Jay, Steven
Associate Professor
Fischell Department of Bioengineering
3116 A. James Clark Hall
EDUCATION
- 2009 - 2013 Postdoctoral Fellow, Brigham and Women's Hospital/Harvard Medical School (PI: Richard T. Lee)
- 2009 - 2013 Visiting Scientist, MIT (PI: Linda Griffith)
- 2004 - 2009 PhD, Yale University (PI: W. Mark Saltzman)
- 2000 - 2004 BSBE, University of Georgia
HONORS AND AWARDS
- 2018 Graduate Faculty Mentor of the Year – University of Maryland
- 2018 CAREER Award – National Science Foundation
- 2018 Associate Scientific Advisory Board Member – Science Translational Medicine
- 2016 Faculty Teaching Award – Fischell Department of Bioengineering, U. of Maryland
- 2016 Young Innovator in Cellular and Molecular Bioengineering – Biomedical Engineering Society
- 2015 Ralph E. Powe Junior Faculty Award – Oak Ridge Associated Universities
- 2013 Innovation and Career Development Award – Biomedical Engineering Society (BMES)
- 2012 Innovative Technology in Cardiovascular Sciences Award – Brigham and Women’s Hospital
- 2012 Innovation in Biotechnology Award – American Association of Pharmaceutical Scientists
- 2012 K99/R00 Pathway to Independence Award – National Institutes of Health
- 2011 Breast Cancer Postdoctoral Fellowship – U.S. Department of Defense
- 2010 F32 NRSA Postdoctoral Fellowship – National Institutes of Health (declined)
- 2009 Henry Prentiss Becton Prize (Outstanding Ph.D. Thesis in Engineering) – Yale University
PROFESSIONAL MEMBERSHIPS
- Biomedical Engineering Society (BMES)
- International Society for Extracellular Vesicles (ISEV)
- American Society of Gene & Cell Therapy (ASGCT)
- Society for Biological Engineering (SBE)
- American Association of Pharmaceutical Scientists (AAPS)
RESEARCH AREAS
Extracellular vesicles, cell therapy, protein therapeutics, drug delivery, biomanufacturing
LAB OVERVIEW
Our research aims to uncover new biological insights towards the design and development of novel biotherapeutics (aka biopharmaceuticals), including proteins, extracellular vesicles (exosomes) and others. We also strive to develop new approaches to drug delivery and biomanufacturing using fundamental tools from both engineering and biology. Employing techniques in molecular biology, protein design and engineering, biomaterials and nanotechnology, we are primarily interested in developing new biotechnologies to address clinical needs in wound repair, cardiovascular disease, cancer, brain and spinal cord injuries, neurological diseases, osteoarthritis, and sepsis, among others. Overarching goals of the lab include developing therapeutics towards clinical translation and endowing trainees with the skills and knowledge necessary to become leaders in the biotechnology and pharmaceutical industries.
PUBLICATIONS
- BIOE340 - Modeling Physiological Systems
- BIOE389C - Bioengineering Design Competitions
- BIOE462 - Therapeutic Development and Delivery
- BIOE612 - Physiological Evaluation of Bioengineering Designs